Clinical trial · Observational
Endometrial Changes in Breast Cancer Women.
Endometrial Changes in Breast Cancer Women: a Prospective Multicentric Trial.
NCT05717634CI-TRIAL-00063729unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective observational multicentric study. The aim is to evaluate the incidence of endometrial cancer and endometrial atypical hyperplasia in patients with previous breast cancer, treated with different adjuvant therapies. The second aim is to identify ultrasonographic soft markers related with endometrial cancer or atipycal hyperplasia.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Endometrial Hyperplasia With Atypia | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | ALIAS | 0.90 |
| TAM | Transient Abnormal Myelopoiesis Associated with Down Syndrome | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hysteroscopy | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- TAM
- description
- Patients with previous breast cancer with hormonal receptor expression that are treated with tamoxifen.
- interventionNames
- Diagnostic Test: Hysteroscopy
- label
- Ais
- description
- Patients with previous breast cancer with hormonal receptor expression that are treated with Ais.
- interventionNames
- Diagnostic Test: Hysteroscopy
- label
- No Therapy
- description
- Patients with previous breast cancer that are not treated with none hormonal therapies.
- interventionNames
- Diagnostic Test: Hysteroscopy
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Personal history of breast cancer Exclusion Criteria: * Personal history of other hormonal sensitive cancers * Assumption of hormones in the previous 5 years * Previous medical assisted reproduction technique * Lynch syndrome or BRCA 1/2 mutations
References
Publications (0)
Data not yet available
No reference posted for this study.